DE69520231D1 - Liposomzubereitungen enthaltend hybrid-interferon - Google Patents

Liposomzubereitungen enthaltend hybrid-interferon

Info

Publication number
DE69520231D1
DE69520231D1 DE69520231T DE69520231T DE69520231D1 DE 69520231 D1 DE69520231 D1 DE 69520231D1 DE 69520231 T DE69520231 T DE 69520231T DE 69520231 T DE69520231 T DE 69520231T DE 69520231 D1 DE69520231 D1 DE 69520231D1
Authority
DE
Germany
Prior art keywords
preparations containing
liposome preparations
containing hybrid
hybrid interferon
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69520231T
Other languages
English (en)
Other versions
DE69520231T2 (de
Inventor
Peter William Taylor
Mohammed Akhlaq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69520231D1 publication Critical patent/DE69520231D1/de
Application granted granted Critical
Publication of DE69520231T2 publication Critical patent/DE69520231T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69520231T 1994-12-08 1995-12-04 Liposomzubereitungen enthaltend hybrid-interferon Expired - Fee Related DE69520231T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426484.3A GB9426484D0 (en) 1994-12-08 1994-12-08 Compositions
PCT/GB1995/002821 WO1996017596A1 (en) 1994-12-08 1995-12-04 Liposomal interferon hybrid compositions

Publications (2)

Publication Number Publication Date
DE69520231D1 true DE69520231D1 (de) 2001-04-05
DE69520231T2 DE69520231T2 (de) 2001-08-16

Family

ID=10766773

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520231T Expired - Fee Related DE69520231T2 (de) 1994-12-08 1995-12-04 Liposomzubereitungen enthaltend hybrid-interferon

Country Status (12)

Country Link
EP (1) EP0799027B1 (de)
JP (1) JPH10510254A (de)
AT (1) ATE199315T1 (de)
AU (1) AU3989295A (de)
CA (1) CA2207292A1 (de)
DE (1) DE69520231T2 (de)
DK (1) DK0799027T3 (de)
ES (1) ES2156218T3 (de)
GB (1) GB9426484D0 (de)
GR (1) GR3035844T3 (de)
PT (1) PT799027E (de)
WO (1) WO1996017596A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006127360A2 (en) * 2005-05-23 2006-11-30 Sdg, Inc. Lipid construct for delivery of interferon to a mammal
EP1909758A1 (de) * 2005-08-02 2008-04-16 I.D.M. Immuno-Designed Molecules Verfahren zur herstelung von liposomalen formulierungen
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same
SG11201908052PA (en) 2017-03-13 2019-09-27 Sdg Inc Lipid-based nanoparticles with enhanced stability

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964024D1 (en) * 1978-10-02 1982-12-16 Procter & Gamble Liposomes for drug delivery and composition containing a liposome drug system
US5023087A (en) * 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
EP0331635A3 (de) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Zubereitungen zur Behandlung von Blasenkrebs.
US5077057A (en) * 1989-04-05 1991-12-31 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
DE4402867C1 (de) * 1994-01-31 1995-06-14 Rentschler Arzneimittel Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen

Also Published As

Publication number Publication date
WO1996017596A1 (en) 1996-06-13
PT799027E (pt) 2001-07-31
GB9426484D0 (en) 1995-03-08
EP0799027B1 (de) 2001-02-28
JPH10510254A (ja) 1998-10-06
ATE199315T1 (de) 2001-03-15
CA2207292A1 (en) 1996-06-13
AU3989295A (en) 1996-06-26
ES2156218T3 (es) 2001-06-16
GR3035844T3 (en) 2001-08-31
DE69520231T2 (de) 2001-08-16
DK0799027T3 (da) 2001-06-18
EP0799027A1 (de) 1997-10-08

Similar Documents

Publication Publication Date Title
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
ATE276742T1 (de) Stabile partikuläre komplexe lamellarer struktur mit neutraler oder negativer gesamtladung
WO1998019709A3 (en) Cationic reagents for transfection
ATE192657T1 (de) Arzneistoffzusammensetzung, die ein nukleinsäurecopolymer enthält
EA199900715A1 (ru) Липидные комплексы и липосомы совершенно нерастворимых комплексов платины
ATE286718T1 (de) Temperatursensitive liposomale formulierung
AU3780497A (en) Improvements in or relating to contrast agents
WO1997011682A3 (en) Emulsion and micellar formulations for the delivery of biologically active substances to cells
AU2284697A (en) Fusogenic liposomes
DE69332276T2 (de) Liposomenzusammensetzung
ATE260643T1 (de) System zur verabreichung makromolekularer wirkstoffe auf der basis von membran-mimetischen amphiphilen in aerosolform
DE69926615D1 (de) Lipidabkömmlinge von pentaerythritol
CA2168260A1 (en) Biphasic Multilamellar Lipid Vesicles
ATE226843T1 (de) Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
DE69520231D1 (de) Liposomzubereitungen enthaltend hybrid-interferon
EP0198765A3 (de) Herstellung von Liposomen
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
AU6083686A (en) Emulsion comprising lipid, non-lipid liquid and pharmaceutical ingredients
GB2188900B (en) Fusogenic phospholipid vesicles.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee